Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP887029.RAobF7HDHE6jivTCw0RHbKaA74KHt1_uWLxv9Sj8Vewkg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP887029.RAobF7HDHE6jivTCw0RHbKaA74KHt1_uWLxv9Sj8Vewkg130_assertion type Assertion NP887029.RAobF7HDHE6jivTCw0RHbKaA74KHt1_uWLxv9Sj8Vewkg130_head.
- NP887029.RAobF7HDHE6jivTCw0RHbKaA74KHt1_uWLxv9Sj8Vewkg130_assertion description "[In this study, the immunomodulator (MDP-Ab) was constructed by coupling anti-CD10 monoclonal antibody (MAb) and muramyl dipeptide (MDP) using heterobifunctional reagent SPDP and the activity of MDP-Ab through dendritic cells (DCs)-based immunotherapy was identified in targeted therapy for leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP887029.RAobF7HDHE6jivTCw0RHbKaA74KHt1_uWLxv9Sj8Vewkg130_provenance.
- NP887029.RAobF7HDHE6jivTCw0RHbKaA74KHt1_uWLxv9Sj8Vewkg130_assertion evidence source_evidence_literature NP887029.RAobF7HDHE6jivTCw0RHbKaA74KHt1_uWLxv9Sj8Vewkg130_provenance.
- NP887029.RAobF7HDHE6jivTCw0RHbKaA74KHt1_uWLxv9Sj8Vewkg130_assertion SIO_000772 21492747 NP887029.RAobF7HDHE6jivTCw0RHbKaA74KHt1_uWLxv9Sj8Vewkg130_provenance.
- NP887029.RAobF7HDHE6jivTCw0RHbKaA74KHt1_uWLxv9Sj8Vewkg130_assertion wasDerivedFrom befree-2016 NP887029.RAobF7HDHE6jivTCw0RHbKaA74KHt1_uWLxv9Sj8Vewkg130_provenance.
- NP887029.RAobF7HDHE6jivTCw0RHbKaA74KHt1_uWLxv9Sj8Vewkg130_assertion wasGeneratedBy ECO_0000203 NP887029.RAobF7HDHE6jivTCw0RHbKaA74KHt1_uWLxv9Sj8Vewkg130_provenance.